RCP Therapeutics Ltd acquires the IP and assets of Telemolecular Corporation
New operational headquarters situated in London, UK
07-Nov-2008 -
RCP Therapeutics, a biopharmaceuticals company specialising in converging nanotechnology and regenerative medical markets, announced that it has exclusively licensed technologies from Telemolecular Corporation (USA). The Company’s portfolio of intellectual property is strategically focused on the ...
biopharmaceuticals
Formation
nanoparticles
+1